A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

The immune checkpoint blockade therapy has profoundly revolutionized the field of cancer immunotherapy. However, despite great promise for a variety of cancers, the efficacy of immune checkpoint inhibitors is still low in colorectal cancer (CRC). This is mainly due to the immunosuppressive feature o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Dandan, Zou, Yifang, Song, Liu, Han, Shulan, Yang, Hao, Chu, Di, Dai, Yun, Ma, Jie, O'Driscoll, Caitriona M., Yu, Zhuo, Guo, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799998/
https://www.ncbi.nlm.nih.gov/pubmed/35127393
http://dx.doi.org/10.1016/j.apsb.2021.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799998/
https://www.ncbi.nlm.nih.gov/pubmed/35127393
http://dx.doi.org/10.1016/j.apsb.2021.06.005

Ejemplares similares